Internal Medicine, Pulmonary Disease · Meridian, ID
NPI
1205034238
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2347 E Gala St
Meridian, ID, 83642
Phone (208) 323-3767
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
484 services
Medicare patients, 2024
254
Average age 75
Drug cost, 2024
$854K
766 prescriptions
Company payments, 2025
$137
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David E Fonseca was code 99213 (office e&m - established), 89 times for 73 patients. In total David E Fonseca billed 484 services in 22 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 89 | 73 | $42.28 | $3,763 |
| 99291 Critical Care E&M | Facility | 60 | 34 | $154.42 | $9,265 |
| 94729 Pulmonary Function Testing | Office | 45 | 45 | $6.33 | $285 |
| 99203 Office E&M - New | Office | 39 | 39 | $59.32 | $2,314 |
| 94729 Pulmonary Function Testing | Facility | 38 | 38 | $5.80 | $221 |
| 94060 Pulmonary Function Testing | Office | 34 | 34 | $7.28 | $247 |
| 94726 Pulmonary Function Testing | Facility | 32 | 32 | $7.95 | $254 |
| 94726 Pulmonary Function Testing | Office | 31 | 31 | $8.49 | $263 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 18 | $57.22 | $1,545 |
| 94060 Pulmonary Function Testing | Facility | 24 | 24 | $6.57 | $158 |
| 94010 Pulmonary Function Testing | Facility | 17 | 17 | $5.26 | $89.4 |
| 94010 Pulmonary Function Testing | Office | 14 | 14 | $5.94 | $83.12 |
By year: 2022 $26K for 557 services; 2023 $22K for 472 services; 2024 $21K for 484 services.
Medicare prescription drug claims, 2024
In 2024, the drug David E Fonseca prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 156 prescriptions and refills. In total David E Fonseca wrote 766 Medicare prescriptions that cost $854K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 156 | 188 | 32 | $121K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 90 | 116 | 32 | $3,144 |
| Prednisone Generic | 62 | 86 | 40 | $415 |
| Azithromycin Generic | 57 | 86 | 20 | $929 |
| Spiriva Respimat Tiotropium Bromide | 57 | 63 | 13 | $32K |
| Incruse Ellipta Umeclidinium Bromide | 35 | 45 | 11 | $15K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 29 | 44 | Under 11 | $2,902 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 25 | 25 | Under 11 | $15K |
| Zemaira Alpha-1-Proteinase Inhibitor | 22 | 22 | Under 11 | $353K |
| Montelukast Sodium Generic | 20 | 36 | Under 11 | $164 |
| Ofev Nintedanib Esylate | 15 | 15 | Under 11 | $185K |
| Arnuity Ellipta Fluticasone Furoate | 13 | 13 | Under 11 | $3,433 |
| Levofloxacin Generic | 12 | 12 | Under 11 | $108 |
| Breo Ellipta Fluticasone/Vilanterol | 12 | 20 | Under 11 | $7,930 |
| Mycophenolate Mofetil Generic | 11 | 11 | Under 11 | $817 |
Brand drugs: 475 claims; generic drugs: 291 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David E Fonseca $137 ($137 in general payments such as food, travel and fees) from 1 company. The largest payer was Penumbra, Inc. with $137.
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. PEN | 1 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.